The GLP-1 Shift in Consumer Eating Habits Consumers on the GLP-1 drug are facing challenges, as their appetite reduces
Some compounding pharmacies also offer sublingual (under-the-tongue) formulations, but these have not been extensively studied and the FDA has raised concerns about salt-form variations
Hepatic Fat Accumulation: GLP-1 RAs were associated with reductions in hepatic steatosis, as reflected by decreases in intrahepatic fat accumulation (IHA) and liver fat content (LFC), both of which are measures of hepatic lipid deposition
Glutathione Side Effects and Precautions Glutathione side effects are rare but can include mild digestive upset, skin rash, or headaches in sensitive individuals
An analysis by sex showed women treated with a GLP-1 agent had an 8% lower risk for obesity-related cancer (HR = 0.92
Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight